[1] 吴燕京, 张月宁, 李鹏, 等. 19例肝脏局灶性结节性增生的临床和影像学特点. 中华消化杂志, 2015, 35: 95-98.
[2] 李秀涛, 罗振东, 李春生, 等. 128层螺旋CT在诊断肝脏局灶性结节增生中的应用. 实用放射学杂志, 2014, 30: 703-704, 709.
[3] Bioulac-Sage P, Balabaud C, Wanless I. WHO Classification tumors of the digested system. Lyon: IARC Press, 2010, 198-204.
[4] 周成香, 刘亚斌, 罗渝昆. 肝脏局灶性结节性增生的超声影像特征. 实用医院临床杂志, 2011, 8: 34-37.
[5] 王丽萍, 谢茶枝. 原发性肝癌介入治疗常见并发症的原因分析与护理. 海南医学, 2010, 21: 142-144.
[6] Schmig M, Eisenhardt A, Ritz E. The Microinflammatory State of Uremia. Blood Purif, 2000, 18: 327-332.
[7] 王乐, 刘斌, 余永强,等. 能谱成像测量单能量下CT值与碘含量的相关性分析. 实用放射学杂志, 2012, 28: 784-787.
[8] 雷立昌, 陈建宇. 能谱CT的临床应用与研究进展. 中国医学影像技术, 2013, 29: 146-149.
[9] Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol, 2008, 48: 163-170.
[10] Asbach P, Klessen C, Koch M, et al. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver. Clin Imaging, 2007, 31: 244-252.
[11] Schima W, Hammerstingl R, Catalano C, et al. Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR, 2006, 186: 1571-1579.
[12] 吕培杰. CT能谱成像在小肝癌检测中的应用价值. 放射学实践, 2011, 26: 321-324.
[13] Shindoh J, Hasegawa K, Inoue Y, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB(Oxford), 2013, 15: 31-39.
[14] Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR, 2008, 190: 28-34.
[15] Yeun JY, Levine RA, Mantadilok V, et al. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2000, 35: 469-476. |
